Finance

Lists
Q3 2026 earnings • released • EPS beat +6.86% • Revenue beat +2.01%
See results
DVA:NYSE
Davita Inc
$185.74
-1.02%
(-1.91) 1D
$185.74
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:04 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DVA...
Open
$186.38
High
$186.38
Low
$180.40
Mkt. cap
11.68B
Avg. vol.
706.75K
Volume
1.00
P/E ratio
13.68
52-wk high
$247.49
52-wk low
$101.00
EPS
$13.58
Beta
0.80
Shares outstanding
62.90M
No. of employees
78K
Open
$186.38
High
$186.38
Low
$180.40
Mkt. cap
11.68B
Avg. vol.
706.75K
Volume
1.00
P/E ratio
13.68
52-wk high
$247.49
52-wk low
$101.00
EPS
$13.58
Beta
0.80
Shares outstanding
62.90M
No. of employees
78K
News stories
From web sources and news partners
Profile
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
About Davita Inc
CEOJavier J. Rodriguez
Employees78K
Founded1992
HeadquartersDenver, Colorado, United States
SectorHealth care provider
Websitedavita.com
Analyst ratings
Based on 6 analysts giving stock ratings to DVA in the past 3 months
Buy
Buy
3
Hold
2
Sell
1
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for DVA in the last 3 months.
Highest
Current $185.74
$287.00 (+54.52%)
Average
$231.83 (+24.81%)
Lowest
$180.00 (-3.09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Langston
TD Cowen
Buy
Reiterated
$228.00
+22.8%
11/02/2026
A.J. Rice
UBS
Buy
Maintained
$287.00
+54.5%
11/02/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$216.00
+16.3%
11/02/2026
Kevin Fischbeck
Bank of America Securities
Sell
Reiterated
$180.00
-3.1%
10/30/2026
David S Macdonald
Truist Financial
Hold
Maintained
$215.00
+15.8%
08/11/2026
Pito Chickering
Deutsche Bank
Buy
Reiterated
$265.00
+42.7%
08/05/2026
Last report
Oct 29, 2026
Fiscal period
Q3 2026
$3.82 / $3.57
+6.86%beat
Revenue / Est. (USD)
3.58B / 3.51B
+2.01%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
3.62B
3.42B
3.55B
3.58B
Cost of goods sold
2.41B
2.34B
2.39B
2.45B
Cost of revenue
2.41B
2.34B
2.39B
2.45B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
472.36M
421.91M
423.46M
408.70M
Operating expense
659.06M
599.74M
591.27M
573.88M
Total operating expenses
3.07B
2.94B
2.98B
3.02B
Operating income
551.20M
473.55M
570.82M
553.19M
Other non operating income
-21.03M
639.00K
4.47M
5.63M
EBT including unusual items
382.76M
341.23M
435.01M
358.71M
EBT excluding unusual items
391.79M
341.23M
437.04M
420.88M
Income tax expense
76.73M
66.20M
91.79M
89.32M
Effective tax rate
20.05%
19.40%
21.10%
24.90%
Other operating expenses
-
-
-
-
Net income
234.22M
197.53M
265.40M
222.93M
Net profit margin
6.47%
5.78%
7.47%
6.23%
Earnings per share
3.40
2.87
4.02
3.82
Interest and investment income
-
-
-
-
Interest expense
-148.25M
-141.30M
-146.42M
-146.18M
Net interest expenses
-148.25M
-141.30M
-146.42M
-146.18M
Depreciation and amortization charges
186.70M
177.83M
167.81M
165.19M
EBITDA
737.91M
651.38M
738.62M
718.38M
Gain or loss from assets sale
-17.55M
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps